Economic evaluation of enoxaparin as prophylaxis against venous thromboembolism in seriously ill medical patients: a US perspective.
about
Pharmacological and clinical differences between low-molecular-weight heparins: implications for prescribing practice and therapeutic interchange.Benefits of novel oral anticoagulant agents for thromboprophylaxis after total hip or knee arthroplasty.Adherence to local guidelines for venous thromboprophylaxis: a cross-sectional study of medical inpatients in Argentina.Venous Thromboembolism Prophylaxis on General Internal Medicine Units: Are Patients Well Served by Current Practice?Venous thromboembolism in medical inpatients--the silent epidemic of neglect
P2860
Economic evaluation of enoxaparin as prophylaxis against venous thromboembolism in seriously ill medical patients: a US perspective.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Economic evaluation of enoxapa ...... al patients: a US perspective.
@en
type
label
Economic evaluation of enoxapa ...... al patients: a US perspective.
@en
prefLabel
Economic evaluation of enoxapa ...... al patients: a US perspective.
@en
P1476
Economic evaluation of enoxapa ...... cal patients: a US perspective
@en
P2093
Gregory de Lissovoy
Prasun Subedi
P304
P577
2002-12-01T00:00:00Z